Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9314464 Compounds and compositions as protein kinase inhibitors

Patent 9314464 was granted and assigned to Novartis on April, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+332 characters)
Article

Patent abstract

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Daniel Poon0
John Tellew0
Shenlin Huang0
Xianming Jin0
Xing Wang0
Yongping Xie0
Yongqin Wan0
Zuosheng Liu0
Edits on 21 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent RE49556 Compounds and compositions as protein kinase inhibitors
0
Edits on 22 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09314464 Compounds and compositions as protein kinase inhibitors US Patent 9314464 Compounds and compositions as protein kinase inhibitors

Infobox
Patent Number
093144640
Patent Number
93144640
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093144640
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novartis
Novartis
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
093144640
Date of Patent
April 19, 2016
0
Patent Application Number
139311110
Date Filed
June 28, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093144640
Patent Primary Examiner
‌
Jason Sims
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09314464
Edits on 6 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09314464 Compounds and compositions as protein kinase inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Novartis
Novartis
Current assignee
Novartis
Novartis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09314464
Date of patent
April 19, 2016
Patent application number
13931111
Date Filed
June 28, 2013
Patent primary examiner
‌
Jason Sims

Find more entities like US Patent 9314464 Compounds and compositions as protein kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.